Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial Carcinoma of the Bladder on Recurrence-free Survival

被引:19
|
作者
Mastroianni, Riccardo [1 ,2 ]
Brassetti, Ado [1 ]
Krajewski, Wojciech [3 ]
Zdrojowy, Romuald [3 ]
Al Salhi, Yazan [4 ]
Anceschi, Umberto [1 ]
Bove, Alfredo Maria [1 ]
Carbone, Antonio [4 ]
De Nunzio, Cosimo [5 ]
Fuschi, Andrea [4 ]
Ferriero, Mariaconsiglia [1 ]
Nacchia, Antonio [5 ]
Pastore, Antonio Luigi [4 ]
Tema, Giorgia [5 ]
Tuderti, Gabriele [1 ]
Gallucci, Michele [2 ]
Simone, Giuseppe [1 ]
机构
[1] Regina Elena Inst Canc Res, Dept Urol, Via Elio Chianesi 53, I-00154 Rome, RM, Italy
[2] Sapienza Univ, Dept Urol, Rome, Italy
[3] Wroclaw Med Univ, Dept Urol & Urol Oncol, Wroclaw, Poland
[4] Sapienza Univ ICOT, Dept Medico Surg Sci & Biotechnol, Urol Unit, Latina, Italy
[5] St Andrea Hosp, Dept Urol, Rome, Italy
来源
EUROPEAN UROLOGY FOCUS | 2021年 / 7卷 / 06期
关键词
Non-muscle-invasive bladder cancer; Detrusor muscle; Transurethral resection of the bladder; Recurrence-free survival; Low-risk bladder cancer; Intermediate-risk bladder cancer; Low-grade bladder cancer; TRANSURETHRAL RESECTION; EUROPEAN ORGANIZATION; INDIVIDUAL PATIENTS; PROGNOSTIC-FACTORS; STAGE TA; CANCER; RISK; CLASSIFICATION; PROGRESSION; NEOPLASMS;
D O I
10.1016/j.euf.2020.08.007
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Obtaining detrusor muscle (DM) in transurethral resection of bladder tumor (TURBt) specimen is considered a surrogate marker of resection quality. However, evidence was principally investigated in high-risk tumors. Therefore, DM sampling for low-grade (LG) urothelial carcinoma (UC) remains poorly investigated and certainly requires further investigation. Objective: To assess whether the absence of DM in TURBt specimen has a negative impact on recurrence-free survival (RFS) in patients with a Ta LG UC. Design, setting, and participants: A multicenter TURBt database was queried for "LG, Ta, UC of the bladder." All patients treated between 1996 and 2018 with tumor grade assessed according to both 1973 World Health Organization and 2004 WHO/International Society of Urological Pathology grading classifications and with a minimum follow-up of 1 yr were included. Patients with a previous history of high-grade UC, upper urinary tract UC, or bladder tumor differentiations other than UC were excluded. Intervention: TURBt. Outcome measurements and statistical analysis: Baseline demographic, clinical, and pathologic data were analyzed. The European Organization for Research and Treatment of Cancer (EORTC) risk group was recorded. Kaplan-Meier analysis was performed to assess the predictive role of clinical and pathologic data for RFS. Univariable and multivariable Cox regression analyses were performed to identify the predictors of recurrence. Results and limitations: Overall, 521 patients were included. At Kaplan-Meier analysis, the low-risk cohort displayed significantly higher RFS than the intermediate-risk cohort (1-yr RFS 87% vs 79%; log-rank p = 0.007). At univariable Cox regression analysis, only gender, multiple tumors, tumor diameter >= 3 cm, and EORTC risk group were significant predictors of recurrence. Absence of DM had no impact on RFS. Multivariable Cox regression analysis confirmed gender and EORTC risk group as independent predictors of recurrence. Conclusions: Absence of DM in TURBt specimen has negligible role in RFS of patients with Ta LG tumors of the bladder. Patient summary: In this study, we assessed the role that detrusor muscle (DM) in transurethral resection of bladder tumor specimen has in recurrence-free survival, in patients with a Ta low-grade urothelial carcinoma of the bladder. Absence of DM has no impact on tumor recurrence; therefore, it does not require additional attention. (C) 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1324 / 1331
页数:8
相关论文
共 50 条
  • [31] Recurrence-free survival following resection of low-grade, Non-Muscle-Invasive Urothelial Cancer (NMIBC): A Southwest Oncology Group (SWOG) S0337 post-hoc analysis
    Corsi, N.
    Sood, A.
    Keeley, J.
    Dalela, D.
    Bronkema, C.
    Rakic, N.
    Stricker, M.
    Novara, G.
    Rogers, C.
    Abdollah, F.
    EUROPEAN UROLOGY, 2021, 79 : S1032 - S1033
  • [32] Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder*
    Reis, Leonard O.
    Taheri, Diana
    Chaux, Alcides
    Guner, Gunes
    Rodriguez, Maria A. Mendoza
    Bivalacqua, Trinity J.
    Schoenberg, Mark P.
    Epstein, Jonathan I.
    Netto, George J.
    HUMAN PATHOLOGY, 2016, 47 (01) : 20 - 25
  • [33] Phosphorylated p70S6K in noninvasive low-grade urothelial carcinoma of the bladder: correlation with tumor recurrence
    Kim, Soon-Ja
    Kim, Jung Hoon
    Jung, Hui Seok
    Lee, Tae-Jin
    Lee, Kyung Mee
    Chang, In Ho
    ASIAN JOURNAL OF ANDROLOGY, 2014, 16 (04) : 611 - 617
  • [34] Single-Dose Post-Office Fulguration Mitomycin C Instillation Appears to Improve Recurrence-Free Survival in Patients With Low-Grade Noninvasive Bladder Cancer
    Halstuch, Daniel
    Lotan, Paz
    Karchever, Idan
    Rubinshtein, Dor
    Kedar, Daniel
    Baniel, Jack
    Golan, Shay
    CLINICAL GENITOURINARY CANCER, 2023, 21 (05) : E320 - E325
  • [35] Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection
    Espiritu, Patrick N.
    Sverrisson, Einar F.
    Sexton, Wade J.
    Pow-Sang, Julio M.
    Poch, Michael A.
    Dhillon, Jasreman
    Spiess, Philippe E.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (05) : 619 - 624
  • [36] Expression of cyclooxygenase-2 is associated with stage, grade and recurrence-free survival in superficial bladder cancer
    Moore, K
    Blackburn, F
    Hovington, H
    Harel, F
    Larue, H
    Lacombe, L
    Fradet, Y
    JOURNAL OF UROLOGY, 2005, 173 (04): : 248 - 248
  • [37] Surgical checklist impact on recurrence-free survival of patients with non-muscle-invasive bladder cancer undergoing transurethral resection of bladder tumour
    Suarez-Ibarrola, Rodrigo
    Soria, Francesco
    Abufaraj, Mohammad
    D'Andrea, David
    Preto, Mirko
    Gust, Kilian M.
    Briganti, Alberto
    Shariat, Shahrokh F.
    Gontero, Paolo
    BJU INTERNATIONAL, 2019, 123 (04) : 646 - 650
  • [38] Does local recurrence impact survival in low-grade chondrosarcoma of the long bones?
    Schwab, Joseph H.
    Wenger, Doris
    Unni, Krishnan
    Sim, Franklin H.
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2007, (462) : 175 - 180
  • [39] Recurrent Ta Low-grade Non-muscle-invasive Bladder Cancer: What Are the Options?
    Roupret, Morgan
    Malmstrom, Per-Uno
    Black, Peter
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (06): : 723 - 729
  • [40] USE OF SURGICAL CHECKLIST DURING TRANSURETHRAL RESECTION INCREASES DETRUSOR MUSCLE COLLECTION RATE AND IMPROVES RECURRENCE-FREE SURVIVAL IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER
    Taoka, Rikiya
    Tsunemori, Hiroyuki
    Harada, Satoshi
    Fujiwara, Kengo
    Matsuda, Iori
    Ito, Ayako
    Yamasaki, Mari
    Tohi, Yoichiro
    Miyauchi, Yasuyuki
    Matsuoka, Yuki
    Kato, Takuma
    Tsunemori, Hiroyuki
    Ueda, Nobufumi
    Sugimoto, Mikio
    JOURNAL OF UROLOGY, 2021, 206 : E305 - E306